FIGURE

FIGURE 3

ID
ZDB-FIG-240430-48
Publication
González-Llera et al., 2023 - An in vivo drug screen in zebrafish reveals that cyclooxygenase 2-derived prostaglandin D2 promotes spinal cord neurogenesis
Other Figures
All Figure Page
Back to All Figure Page
FIGURE 3

PGDS/PGD2/cAMP signalling promotes the generation of serotonergic neurons (red fluorescence) in the ventral spinal cord. (A) Treatments with the PGDS inhibitors hPGDS‐IN‐1 (4.132 ± 0.366 cells, n = 53; Mann–Whitney test; p‐value <0.0001) and AT‐56 (8.179 ± 0.392 cells, n = 39; Unpaired t‐test; p‐value = 0.0045) reduced the numbers of serotonergic neurons in the ventral spinal cord as compared to DMSO controls (hPGDS‐IN‐1 controls: 6.660 ± 0.359 cells, n = 47; AT‐56 controls: 9.696 ± 0.343 cells, n = 46). A treatment with PGD2 methyl ester (2.5 μM; 11.18 ± 0.546 cells, n = 34; Unpaired t‐test; p‐value = 0.8421) does not significantly change the number of serotonergic neurons in the spinal cord of 4 dpf zebrafish as compared to DMSO controls (11.06 ± 0.282 cells, n = 36). (B) A co‐treatment of S(+)‐Ibuprofen (10 μM) with 2.5 μM PGD2 methyl ester (9.154 ± 0.364 cells, n = 52; Kruskal–Wallis test; p‐value = 0.071) was able to rescue the inhibitory effects of an S(+)‐Ibuprofen treatment (7.333 ± 0.295 cells, n = 42; Kruskal–Wallis test; p‐value <0.0001) on the generation of 5‐HT‐ir spinal cord neurons. Numbers of serotonergic neurons in S(+)‐Ibuprofen and PGD2 methyl ester treated zebrafish were not significantly different as compared to DMSO controls (10.21 ± 0.283 cells, n = 34). C. S(+)‐Ibuprofen and Rolipram treated 4 dpf zebrafish showed numbers of 5‐HT‐ir neurons (10.19 ± 0.361 cells, n = 47; Kruskal–Wallis test; p‐value = 0.9081) similar to DMSO controls (10.88 ± 0.411 cells, n = 50) and that were significantly higher than S(+)‐Ibuprofen treated (8.375 ± 0.489 cells, n = 48; Kruskal–Wallis test; p‐value = 0.0006) zebrafish. 4 dpf zebrafish treated with S(+)‐Ibuprofen and Rolipram (245.3 ± 45.66 cm, n = 89; Kruskal–Wallis test; p‐value = 0.0315) showed increased locomotor activity as compared to S(+)‐Ibuprofen (198.7 ± 56.07 cm, n = 88; Kruskal–Wallis test; p‐value <0.0001) treated zebrafish (Figure 3D). However, locomotor activity in S(+)‐Ibuprofen and Rolipram treated zebrafish was still significantly lower than in DMSO controls (445.2 ± 79.30 cm, n = 85). Rostral is to the right and dorsal to the top in all photomicrographs. Scale bars: 25 μm.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Prolif.